Cargando…
Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan
BACKGROUND: Globally metronidazole and carbapenem resistance in anaerobic organisms is increasing necessitating continuous surveillance to guide selection of empirical treatment. In this study we have determined metronidazole resistance in anaerobes using MIC Evaluator strips (M.I.C.E strips). Carba...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567479/ https://www.ncbi.nlm.nih.gov/pubmed/31210928 http://dx.doi.org/10.1186/s13756-019-0549-8 |
_version_ | 1783427087145631744 |
---|---|
author | Shafquat, Yusra Jabeen, Kauser Farooqi, Joveria Mehmood, Kiran Irfan, Seema Hasan, Rumina Zafar, Afia |
author_facet | Shafquat, Yusra Jabeen, Kauser Farooqi, Joveria Mehmood, Kiran Irfan, Seema Hasan, Rumina Zafar, Afia |
author_sort | Shafquat, Yusra |
collection | PubMed |
description | BACKGROUND: Globally metronidazole and carbapenem resistance in anaerobic organisms is increasing necessitating continuous surveillance to guide selection of empirical treatment. In this study we have determined metronidazole resistance in anaerobes using MIC Evaluator strips (M.I.C.E strips). Carbapenem resistance was evaluated only in metronidazole resistant isolates. MATERIAL AND METHODS: The study was conducted at the Aga Khan University (AKU) Hospital laboratory, Karachi, Pakistan (2014–2017). Metronidazole and imipenem resistance was evaluated using M.I.C.E strips and minimum inhibitory concentrations (MICs) were interpreted using Clinical Laboratory Standards Institute (CLSI) criteria. Clinical details including demographics, prolonged hospital stay, malignancy, transplant, dialysis, diabetes, site of infection and outcome were analyzed for association with metronidazole resistance. RESULTS: Of the 223 clinically significant isolates, 39 (17.5%) were metronidazole resistant (excluding the inherently resistant organisms; for example Cutibacterium species). Imipenem resistance was determined in 29 metronidazole resistant isolates and of these 7 (24.1%) were found to be resistant. Proportion of metronidazole resistant strains was highest amongst Bacteroides species. A significant increase in metronidazole resistance from 12.3% in 2010–2011 to 17.5% in the current study was found. Carbapenem resistance also emerged in the period 2014–2017. Isolates from malignancy and transplant patients showed lower odds of developing metronidazole resistance (0.003(95% CI: 1.7–17.9)). Prolonged hospital stay was not associated with metronidazole resistance (1.1((95% CI: 0.5–2.5)). CONCLUSION: The rising trend of metronidazole resistance and emergence of carbapenem resistance in anaerobic bacteria is alarming. Continued surveillance with strengthening of laboratory capacity regarding anaerobic susceptibility testing is urgently needed in Pakistan. |
format | Online Article Text |
id | pubmed-6567479 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65674792019-06-17 Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan Shafquat, Yusra Jabeen, Kauser Farooqi, Joveria Mehmood, Kiran Irfan, Seema Hasan, Rumina Zafar, Afia Antimicrob Resist Infect Control Research BACKGROUND: Globally metronidazole and carbapenem resistance in anaerobic organisms is increasing necessitating continuous surveillance to guide selection of empirical treatment. In this study we have determined metronidazole resistance in anaerobes using MIC Evaluator strips (M.I.C.E strips). Carbapenem resistance was evaluated only in metronidazole resistant isolates. MATERIAL AND METHODS: The study was conducted at the Aga Khan University (AKU) Hospital laboratory, Karachi, Pakistan (2014–2017). Metronidazole and imipenem resistance was evaluated using M.I.C.E strips and minimum inhibitory concentrations (MICs) were interpreted using Clinical Laboratory Standards Institute (CLSI) criteria. Clinical details including demographics, prolonged hospital stay, malignancy, transplant, dialysis, diabetes, site of infection and outcome were analyzed for association with metronidazole resistance. RESULTS: Of the 223 clinically significant isolates, 39 (17.5%) were metronidazole resistant (excluding the inherently resistant organisms; for example Cutibacterium species). Imipenem resistance was determined in 29 metronidazole resistant isolates and of these 7 (24.1%) were found to be resistant. Proportion of metronidazole resistant strains was highest amongst Bacteroides species. A significant increase in metronidazole resistance from 12.3% in 2010–2011 to 17.5% in the current study was found. Carbapenem resistance also emerged in the period 2014–2017. Isolates from malignancy and transplant patients showed lower odds of developing metronidazole resistance (0.003(95% CI: 1.7–17.9)). Prolonged hospital stay was not associated with metronidazole resistance (1.1((95% CI: 0.5–2.5)). CONCLUSION: The rising trend of metronidazole resistance and emergence of carbapenem resistance in anaerobic bacteria is alarming. Continued surveillance with strengthening of laboratory capacity regarding anaerobic susceptibility testing is urgently needed in Pakistan. BioMed Central 2019-06-14 /pmc/articles/PMC6567479/ /pubmed/31210928 http://dx.doi.org/10.1186/s13756-019-0549-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Shafquat, Yusra Jabeen, Kauser Farooqi, Joveria Mehmood, Kiran Irfan, Seema Hasan, Rumina Zafar, Afia Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan |
title | Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan |
title_full | Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan |
title_fullStr | Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan |
title_full_unstemmed | Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan |
title_short | Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan |
title_sort | antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from pakistan |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567479/ https://www.ncbi.nlm.nih.gov/pubmed/31210928 http://dx.doi.org/10.1186/s13756-019-0549-8 |
work_keys_str_mv | AT shafquatyusra antimicrobialsusceptibilityagainstmetronidazoleandcarbapeneminclinicalanaerobicisolatesfrompakistan AT jabeenkauser antimicrobialsusceptibilityagainstmetronidazoleandcarbapeneminclinicalanaerobicisolatesfrompakistan AT farooqijoveria antimicrobialsusceptibilityagainstmetronidazoleandcarbapeneminclinicalanaerobicisolatesfrompakistan AT mehmoodkiran antimicrobialsusceptibilityagainstmetronidazoleandcarbapeneminclinicalanaerobicisolatesfrompakistan AT irfanseema antimicrobialsusceptibilityagainstmetronidazoleandcarbapeneminclinicalanaerobicisolatesfrompakistan AT hasanrumina antimicrobialsusceptibilityagainstmetronidazoleandcarbapeneminclinicalanaerobicisolatesfrompakistan AT zafarafia antimicrobialsusceptibilityagainstmetronidazoleandcarbapeneminclinicalanaerobicisolatesfrompakistan |